Advanced Therapy Registry of IBD Patients
NCT04998084 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2022-07-22
Summary
The study is aim to detect common microbial profiles and metabolic pathways throughout IBD diagnosis and treatment with biological therapy.
Conditions
- Crohn Disease
- Ulcerative Colitis
- Pouchitis
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-28
- Primary Completion
- 2024-06-27
- Completion
- 2025-06-27
Countries
- Israel
Study Locations
More Related Trials
-
Microflora and Metabolomics of Crohn's Disease Patients
NCT04965584 ·Status: UNKNOWN
-
Immunological Characteristics of Patients With PID and IBD
NCT03148028 ·Status: UNKNOWN
-
Inflammatory Bowel Disease(IBD)Database
NCT01266538 ·Status: NOT_YET_RECRUITING
-
Inflammatory Bowel Diseases Remission Registry
NCT04912999 ·Status: RECRUITING
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA
-
Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in Inflammatory Bowel Disease (IBD)
NCT00915044 ·Status: UNKNOWN
-
Immune Ablation and Stem Cell Support for Crohn's Disease
NCT00179842 ·Status: WITHDRAWN ·Phase: PHASE2
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.
NCT07172945 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study to Determine Relationship Between Serum Infliximab and Efficacy in Luminal Crohn's Disease Patients
NCT00676988 ·Status: COMPLETED
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease
NCT01349504 ·Status: COMPLETED
-
Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)
NCT01349920 ·Status: COMPLETED
-
A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)
NCT05596422 ·Status: COMPLETED
-
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
NCT02054533 ·Status: COMPLETED
-
Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)
NCT00705614 ·Status: COMPLETED
-
CorEvitas Inflammatory Bowel Disease (IBD) Registry
NCT03162549 ·Status: ENROLLING_BY_INVITATION
-
Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
NCT03264690 ·Status: COMPLETED
-
Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases
NCT02878395 ·Status: UNKNOWN
-
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
NCT01290042 ·Status: COMPLETED ·Phase: PHASE1
-
MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach.
NCT04272307 ·Status: UNKNOWN
-
Fecal Microbiota Transplantation and Analysis of Fecal Microbiome in IBD Patients
NCT03399188 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Mycobiome Supplementation on Gastrointestinal Symptoms in IBD Patients
NCT04329481 ·Status: UNKNOWN ·Phase: NA
-
Early Inflammatory Bowel Disease Progression
NCT06756100 ·Status: RECRUITING
-
Biologics in Management of Inflammatory Bowel Disease in Egyptian Patients
NCT05720221 ·Status: COMPLETED